Given that Chinese counterfeiting has benefits as well as costs, and considering China's historical resistance to Western pressure, trying to push China to change its approach to intellectual property law is not worth the political and diplomatic capital the United States is spending on it.
Two controversial U.S. anti-piracy bills have spotlighted the growing challenge of how to protect intellectual copyrights, particularly across international borders, without compromising Internet freedom.
One of the most contentious issues in the Trans-Pacific Partnership negotiations is related to intellectual property and medicines. CFR’s Laurie Garrett reviews the intensifying debate among industry and global health advocates.
A critique of the U.S. Patent and Trademark Office's practice of denying patents for new financial services products unless they are connected to the "technological arts." The article shows that this restriction on patentability has no grounding in U.S. patent law or precedent and does little to address the larger and more important issue of dwindling patent quality.
Reforms of the U.S. patent system have made it too easy to obtain and defend patents and more costly to challenge patent decisions, thereby limiting the competition of ideas, discouraging innovation, and ultimately reducing U.S. competitiveness, argues a new Council Special Report.
U.S. trade is increasingly dependent on high-technology and innovation-intensive goods. Many companies share a reliance on innovation and export and, therefore, an interest in ensuring adequate intellectual property protection for their products worldwide. This report examiens the scourge of piracy, which affects the symbols of U.S. economic strength and greatest hope for the future--modern information-intensive industries.
The U.S. Department of Justice announced the indictment of five Chinese military hackers on May 19, 2014. Wang Dong, Sun Kailiang, Wen Xinyu, Huang Zhenyu, and Gu Chunhui were charged with computer hacking, economic espionage and other offenses directed at Americans in the nuclear power, metals, and solar products industries.
The Supreme Court ruled on June 13, 2013, that Myriad Genetics could not patent human genes they isolated from the bloodstream, because the company "did not create anything," but that synthetic forms of the genes may be eligible for patents.
The Commission on the Theft of American Intellectual Property (The IP Commission), with members from the "private sector and public service in national security and foreign affairs, academe, and politics," released its report on May 22, 2013. The Commission addresses theft by cyber means and pinpoints China as a main concern.
Learn more about CFR’s mission and its work over the past year in the 2015 Annual Report. The Annual Report spotlights new initiatives, high-profile events, and authoritative scholarship from CFR experts, and includes a message from CFR President Richard N. Haass. Read and download »